Search

everythinglearnresearchcommunity

for

Search:↓

Men with early baldness have similar heart risk factors as others, but certain proteins are linked to higher heart disease risk.

Patients with mycosis fungoides have a higher risk of heart disease.

Lisinopril improves heart health more in men with normal hair than those with early hair loss.

Women with non-classic congenital adrenal hyperplasia have higher risk for heart and metabolic problems.

Increased HSD11B1 enzyme expression is linked to higher body fat and insulin resistance.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Metformin is less effective in men with early-onset hair loss.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

African American women have a higher risk of preterm delivery than Caucasian women, and inflammatory stimuli affect gene expression in cells related to PCOS, showing a heightened inflammatory state in women with PCOS.

Lifestyle changes improve metabolism and fertility in overweight PCOS patients; anti-obesity drugs show potential but need more research.

People with psoriasis are more likely to have Metabolic Syndrome than those without psoriasis.

Children with classic congenital adrenal hyperplasia have thicker heart fat and are at higher risk for heart problems and early atherosclerosis.

Men with early-onset hair loss have less cardiometabolic benefit from bromocriptine.

Lotion with fucoidan from brown seaweed improved skin and reduced allergy symptoms in mice with dermatitis.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Vitamin D may help reduce antibody levels in men with autoimmune thyroiditis and early-onset androgenic alopecia, but has no significant impact on thyroid function.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

Women with PCOS may have a higher risk of severe COVID-19 due to hormonal imbalances and vitamin D deficiency.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

The Rotterdam Study aims to understand various diseases in older adults.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Proper nutrition can help manage PCOS symptoms and improve overall health.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

PCOS is a complex condition in women that can lead to health issues, and lifestyle changes are the best management approach.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

The conclusion is that obesity should be managed with a slow, balanced approach to diet and exercise, with medication and surgery as additional options, and education and access to care are important.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

The document concludes that more research is needed to fully understand the causes of PCOS.